ConductScience.org, home

Paper30803

Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas.

Giebink GS and 3 others. J Infect Dis, 1978. Cited by 41 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. Papers, record 30803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30803

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas.
PubMed
Journal
J Infect Dis
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giebink GSG S
2Schiffman GG
3Petty KK
4Quie PGP G

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Otitis MediaMajor topic
Polysaccharides, BacterialMajor topic
Streptococcus pneumoniaeMajor topic
VaccinationMajor topic
Animals
Antibodies, Bacterial
Chinchilla
Disease Models, Animal
Sepsis

Source PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
11,292,713Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.Infect Immun2001https://conductscience.org/library/papers/11292713PubMed
8,878,566Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8878566PubMed
8,215,269Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8215269PubMed
7,439,990Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.Infect Immun1980https://conductscience.org/library/papers/7439990PubMed
7,399,697Antigenicity and protective effects of type 3 pneumococcal polysaccharide in rats.Infect Immun1980https://conductscience.org/library/papers/7399697PubMed
7,076,299Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media.Infect Immun1982https://conductscience.org/library/papers/7076299PubMed
6,979,517Experimental otitis media in gerbils and chinchillas with Streptococcus pneumoniae, Haemophilus influenzae, and other aerobic and anaerobic bacteria.Infect Immun1982https://conductscience.org/library/papers/6979517PubMed
6,885,170Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas.Infect Immun1983https://conductscience.org/library/papers/6885170PubMed
6,832,812Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.Infect Immun1983https://conductscience.org/library/papers/6832812PubMed
3,366,870Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.J Clin Microbiol1988https://conductscience.org/library/papers/3366870PubMed
1,452,327Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex.Infect Immun1992https://conductscience.org/library/papers/1452327PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30803

GET https://conductscience.org/api/papers/v1/30803/authors